VSM MedTech Announces $4.3 Million Sale To NIH Upheld U.S. General Accounting Office Denies Protest (CCN Newswire) ... develops and manufactures proprietary technology for MEG, which gives precise information on the brain`s function including touch, speech, vision, hearing and motor skills.......This technology is approved for use in pre-surgical assessment of tumors, epilepsy tissue and localization of trauma, cognitive and psychological disorders.... - Oct 11 6:08 PM ET


IF the story does not appear below, Click HERE to view the text of the story!
Note: The original website is displayed below - we have no control over it and are not responsible for the content of it, we just report it! IF you click on anything below, it will take you off of our website!
Original Source: https://biz.yahoo.com/ccn/011011/wawebc720xz59loaec9xhw_1.html


(Everything below this line is from virtualtrials.org!)

Click HERE to return to brain tumor news headlines.